tiprankstipranks
Syndax price target raised to $43 from $35 at BTIG
PremiumThe FlySyndax price target raised to $43 from $35 at BTIG
1M ago
Syndax price target raised to $51 from $49 at H.C. Wainwright
Premium
The Fly
Syndax price target raised to $51 from $49 at H.C. Wainwright
1M ago
Syndax confirms FDA approval of Revuforj for acute leukemia
Premium
The Fly
Syndax confirms FDA approval of Revuforj for acute leukemia
1M ago
Leerink views Syndax data as potentially positive for Kura Oncology’s ziftomenib
PremiumThe FlyLeerink views Syndax data as potentially positive for Kura Oncology’s ziftomenib
1M ago
Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
Premium
The Fly
Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
1M ago
Syndax’s revumenib meets primary results in AML trial
Premium
The Fly
Syndax’s revumenib meets primary results in AML trial
1M ago
Syndax to present new data on revumenib in leukemia
PremiumThe FlySyndax to present new data on revumenib in leukemia
2M ago
Royalty Pharma enters $350M synthetic royalty funding agreement with Syndax
Premium
The Fly
Royalty Pharma enters $350M synthetic royalty funding agreement with Syndax
2M ago
Syndax, Royalty Pharma enter $350M royalty funding agreement for Niktimvo
Premium
The Fly
Syndax, Royalty Pharma enter $350M royalty funding agreement for Niktimvo
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100